LP
AEON icon

LMR Partners’s AEON Biopharma AEON Stock Holding History

LMR Partners’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-679
Closed -$26.4K – 1338
2024
Q4 		$26.4K Hold
679
– – ﹤0.01% 1066
2024
Q3 		$51.3K Sell
679
-84
-11% -$7.39K ﹤0.01% 1075
2024
Q2 		$57.7K Buy
763
+671
+729% +$160K ﹤0.01% 919
2024
Q1 		$76.7K Buy
+92
New +$66.6K ﹤0.01% 944
2023
Q1 		– Sell
-8,333
Closed -$6.03M – 1011
2022
Q4 		$6.03M Hold
8,333
– – 0.11% 233
2022
Q3 		$5.91M Hold
8,333
– – 0.11% 232
2022
Q2 		$5.89M Hold
8,333
– – 0.1% 250
2022
Q1 		$5.87M Hold
8,333
– – 0.07% 296
2021
Q4 		$5.83M Hold
8,333
– – 0.06% 238
2021
Q3 		$5.84M Hold
8,333
– – 0.07% 226
2021
Q2 		$5.78M Buy
+8,333
New +$5.83M 0.09% 186

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

LMR Partners's AEON Position: Q1 2025 in Review

LMR Partners sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 679 shares — an estimated $26.4K sold.

LMR Partners first reported a position in AEON in Q2 2021 and held it in 11 quarters. The position peaked at $6.03M in Q4 2022. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

  • LMR Partners reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 679 AEON Biopharma shares in Q1 2025, an estimated $26.4K.
  • LMR Partners first reported a position in AEON Biopharma in Q2 2021 and held it in 11 quarters.
  • LMR Partners's AEON Biopharma position peaked at $6.03M in Q4 2022.
  • 16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.